As gene and cell therapies mature, developers are increasingly looking beyond existing delivery systems to address challenges around targeting, immunogenicity, manufacturability, and cost. Dr. Angelo ...
Gastroenterologist Stephanie D. Pointer, MD, has seen a noticeable increase in patients presenting with acute gastrointestinal illness this winter. Many have tested positive for norovirus on stool ...
Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, metastatic, non-squamous, non-small cell lung cancer ...
The emergence of highly diverse sub-lineages within the SARS-CoV-2 Omicron variant poses a significant threat to the efficacy of existing COVID-19 vaccines, leading to breakthrough infections and ...
New research led by Flinders University and international experts has finally uncovered how a rare blood clotting condition can occur after some COVID19 adenovirus-based vaccines or after a natural ...
Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results